Æȷοì
Christopher Szeto
Christopher Szeto
Exelixis, Inc.
exelixis.comÀÇ À̸ÞÀÏ È®ÀÎµÊ - ȨÆäÀÌÁö
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Comprehensive molecular portraits of human breast tumours
Brigham & Women¡¯s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
114852012
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
77532012
Integrated genomic analyses of ovarian carcinoma
D Bell, A Berchuck, M Birrer, J Chien, DW Cramer, F Dao, R Dhir, P Disaia, ...
Nature Publishing Group 474 (7353), 609-615, 2011
71112011
Integrated genomic characterization of endometrial carcinoma
DA Levine, ...
Nature 497 (7447), 67-73, 2013
51842013
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
37882012
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM
CJ Vaske, SC Benz, JZ Sanborn, D Earl, C Szeto, J Zhu, D Haussler, ...
Bioinformatics 26 (12), i237-i245, 2010
9102010
Distributed machine learning systems, apparatus, and methods
C Szeto, SC Benz, NJ Witchey
US Patent 11,461,690, 2022
2882022
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
GS Wong, J Zhou, JB Liu, Z Wu, X Xu, T Li, D Xu, SE Schumacher, ...
Nature medicine 24 (7), 968-977, 2018
2552018
The UCSC cancer genomics browser
J Zhu, JZ Sanborn, S Benz, C Szeto, F Hsu, RM Kuhn, D Karolchik, ...
Nature methods 6 (4), 239-240, 2009
2022009
A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival
MI Jaber, B Song, C Taylor, CJ Vaske, SC Benz, S Rabizadeh, ...
Breast Cancer Research 22, 1-10, 2020
952020
The UCSC cancer genomics browser: update 2011
JZ Sanborn, SC Benz, B Craft, C Szeto, KM Kober, L Meyer, CJ Vaske, ...
Nucleic acids research 39 (suppl_1), D951-D959, 2011
742011
The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex
C Jochems, SR Tritsch, KM Knudson, SR Gameiro, CS Rumfield, ...
Oncoimmunology 8 (2), e1532764, 2019
382019
Large scale, robust, and accurate whole transcriptome profiling from clinical formalin-fixed paraffin-embedded samples
Y Newton, AJ Sedgewick, L Cisneros, J Golovato, M Johnson, CW Szeto, ...
Scientific reports 10 (1), 17597, 2020
322020
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
F Loupakis, G Maddalena, I Depetris, S Murgioni, F Bergamo, AP Dei Tos, ...
Journal for ImmunoTherapy of Cancer 7, 1-7, 2019
322019
Transcriptomic silencing as a potential mechanism of treatment resistance
JJ Adashek, S Kato, R Parulkar, CW Szeto, JZ Sanborn, CJ Vaske, ...
JCI insight 5 (11), 2020
272020
Molecular basis of a dominant SARS-CoV-2 spike-derived epitope presented by HLA-A* 02: 01 recognised by a public TCR
C Szeto, AT Nguyen, CA Lobos, DSM Chatzileontiadou, D Jayasinghe, ...
Cells 10 (10), 2646, 2021
222021
Ensemble-Based Research Recommendation Systems And Methods
C Szeto
US Patent App. 15/555,290, 2018
182018
Association of differential expression of immunoregulatory molecules and presence of targetable mutations may inform rational design of clinical trials
CW Szeto, R Kurzrock, S Kato, A Goloubev, S Veerapaneni, A Preble, ...
ESMO open 7 (1), 100396, 2022
132022
Systems and methods for response prediction to chemotherapy in high grade bladder cancer
C Szeto
US Patent 11,101,038, 2021
132021
Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study
L Drusbosky, C Nangia, A Nguyen, C Szeto, Y Newton, P Spilman, ...
Journal for immunotherapy of cancer 8 (2), 2020
132020
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20